Cantor sees NASA initiatives boosting Rocket Lab, Intuitive Machines

Intuitive Machines won a $180M NASA CLPS contract to deliver payloads to the lunar South Pole. Rocket Lab completed its 85th mission (6th this year) and reaffirmed a first Neutron launch target in Q4 2026. Satellogic expanded a partnership with the U.S. Office of Naval Research/Innovative Defense Technologies to supply two NewSat Mark V satellites in summer 2026 and six Mark VI by 2027, its stock has surged 217% YTD to $5.93 despite remaining unprofitable (72% gross margin), and Cantor Fitzgerald reiterated an Overweight while highlighting the Merlin system with an Oct 2026 launch. Sector momentum may be further amplified by interest around a potential SpaceX IPO that could raise over $75B.

Analysis

The constellation of increased commercial activity lifts demand for end-to-end mission services more than any single launcher or imagery vendor; the non-obvious beneficiaries are payload-integration shops, radiation-hardened electronics suppliers, and hosted-payload brokers whose revenue scales with mission cadence and are less capital intensive than builders. As cadence rises, expect lead times for COTS subsystems (star trackers, reaction wheels, rad-hard FPGAs) to lengthen, creating pricing power for specialized suppliers and a choke-point that can delay revenue recognition for vehicle and satellite OEMs.

Capital structure divergence is the main second-order dynamic: firms with recurring government/defense contracts can de-risk growth without tapping public markets, while high-margin but unprofitable imagery firms face binary dilution risk if cash runs short. Insurance and liability costs are an underappreciated margin lever — a cluster of failures or a single high-visibility loss will rapidly lift launch insurance premia and compress gross economics for smaller operators over 6–18 months.

Near-term reversal catalysts sit squarely on execution: flight-test outcomes, milestone payments, and cash runway conversations will move equity more than headline commercial partnerships. Macro risks (rate-driven valuation compression) and a crowded IPO/secondary pipeline could precipitate multiple contraction within 3–12 months for names priced for perfection. Longer term (2–5 years), companies that convert technical capability into sticky data/recurring service contracts will re-rate; manufacturing-led firms without recurring revenue will remain at valuation risk.

Given these dynamics, prefer exposures that monetize recurring service stacks or possess contracted government demand; avoid purer-play imagery/platform names that are high-burn and valuation-sensitive without visible annuity-like revenue. Use option structures around binary technical milestones to limit downside while keeping upside optionality.

Key Decisions for Investors

• Long LUNR equity sized 2-3% portfolio, horizon 12–18 months — thesis: favor operators with clearer path to repeatable tasking; hedge with a 10% OTM put (6–9 month) to cap downside if a development failure shocks sentiment. Target upside: 2x if milestone cadence proves out; capped loss to put premium + equity delta (~10–15%).
• Pair trade: long LUNR / short SATL (equal notional) over 9–12 months — rationale: long the higher-probability contract revenue stream, short the higher-burn imagery/scale story subject to dilution. Risk: execution mismatch—use monthly rebalancing and size to 1–2% net portfolio exposure; expected asymmetric payoff if funding concerns surface (short benefits).
• Sell covered calls on RKLB (3–6 month expiries) against a core position to monetize implied volatility ahead of flight-test windows; if comfortable with binary risk, replace part of the covered-call proceeds with staggered long-dated puts to protect against catastrophic test failure. Reward: collect premium while retaining some upside; risk: capped upside and residual tail exposure covered by puts.
• Buy SATL 9–12 month put spread (long put / sell lower strike put) as a directional hedge against dilution-driven drawdown — limited-cost bearish play that profits from multiple compression or financing events. Structure to limit max loss to premium paid while targeting 30–60% downside capture on the equity leg if a financing re-rate occurs.